Nabumetone Tablet
Product Images NDC 68788-7597

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 68788-7597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nabumentone Tablets 750mg (Container3)

Label for Nabumetone Tablets 750 mg by Preferred Pharmaceuticals Inc. The label states the product is generic for Relafen, contains 750 mg tablets, oval white tablets imprinted with 466 / SG. It includes directions for use in English and Spanish on a yellow background, along with storage instructions and manufacturer details (ScieGen Pharmaceuticals, Inc.). Several placeholders for lot number, batch, expiration date, and quantity are also shown.*

FDA Label Image

Figure1 (Figure1)

A pharmacokinetic graph showing Nabumetone active metabolite (6MNA) plasma concentrations over time following once-daily dosing of Nabumetone at 1000 mg and 2000 mg. The chart plots concentration (ng/mL) versus time (hours) with shaded areas representing ±2 standard deviations for each dose group.*

FDA Label Image

Structure1 (Structure1)

Chemical structure of Nabumetone depicting its molecular framework including aromatic rings, a methoxy group, and a ketone functional group.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of Nabumetone, showing its molecular framework with a methoxy group and carboxylic acid functional group attached to a fused aromatic ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.